TNFRSF17 and Miyoshi myopathy: On the other hand, several antigens have been used as targets for MM in both preclinical and clinical studies, including B cell maturation antigen (BCMA), CD19, CD138, immunoglobulin light chains, signalling lymphocytic activation molecule 7 (SLAM7), and so forth [3,10,11].